BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Xeris Pharmaceuticals  

3925 West Braker Lane, Third Floor

Austin  Texas  78759  U.S.A.
Phone: 512-534-8340 Fax: n/a


SEARCH JOBS





Segment
Start Up





 Company News
Xeris Pharmaceuticals Receives U.S. Patent For Its Novel, Stable Non-Aqueous Glucagon Formulations 4/16/2014 9:19:55 AM    More...
Xeris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of its Investigational Soluble Glucagon Formulation 10/18/2013 9:32:31 AM    More...
Xeris Pharmaceuticals Presents Non-Aqueous Glucagon Stability Data at the American Diabetes Association 73nd Scientific Sessions 6/21/2013 9:34:35 AM    More...
Xeris Pharmaceuticals Awarded Phase II Funding of National Institutes of Health (NIH) Fast -Track SBIR Grant to Advance Glucagon for the Artificial Pancreas 4/17/2013 11:18:20 AM    More...
Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance Stable, Non-Aqueous Glucagon for Bi-Hormonal Artificial Pancreas 7/31/2012 9:20:55 AM    More...
Xeris Pharmaceuticals Receives U.S. Patent for Injection of Ultra-Concentrated Drugs and Biologics 3/20/2012 9:34:11 AM    More...
Xeris Pharmaceuticals Closes US$1.5 Million Series A Financing with Central Texas Angel Network 12/12/2011 8:14:27 AM    More...